CASEY MORRIS: Open Payments
NPI 1518621739 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 11 payments from 4 companies in 2025. Trend: 2023 $2,836 · 2024 $290 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $278 |
| Sumitomo Pharma America, Inc. | 1 | $93 |
| Janssen Scientific Affairs, LLC | 1 | $90 |
| Madrigal Pharmaceuticals | 1 | $44 |
Products named: VRAYLAR, MAVYRET, GEMTESA, TREMFYA, REZDIFFRA, RINVOQ, SKYRIZI.
Industry payments across AR — which companies pay providers there.
